Since Onconova Therapeutics was founded in 1998, it has participated in 10 rounds of funding. In total Onconova Therapeutics has raised $211.0M. Onconova Therapeutics' last funding round was on Sep 2021 for a total of $21.0M.
Onconova Therapeutics has 2 investors, including Ladenburg Thalmann & Co. Inc. and Noble Capital Markets, Inc. The latest investment occurred in Sep 2021.